Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05390606 · ClinicalTrials.gov registry record · Phase 1
Effects of Flourish HEC and BioGenesis to Improve Conception
A Phase 1 study, sponsored by Vaginal Biome Science.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT05390606: Clinical Trial Phase 1 study, sponsored by Vaginal Biome Science.
NCT05390606 is a Phase 1 study that was terminated before completion, run by Vaginal Biome Science. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05390606, a Phase 1 study, was terminated before completion, sponsored by Vaginal Biome Science.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study intends to address whether improving the vaginal microbiome can help couples increase chances of conceiving.
Primary Outcome
Percentage of women becoming pregnant at home within the 3 month study.
Interventions
- COMBINATION_PRODUCT Flourish HEC and BioGenesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-03-20 |
| Phase | Phase 1 |
Why NCT05390606 stopped before completion
NCT05390606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Flourish HEC and BioGenesis is the first listed.
NCT05390606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05390606 about?
NCT05390606 is a clinical study titled "Effects of Flourish HEC and BioGenesis to Improve Conception". This study intends to address whether improving the vaginal microbiome can help couples increase chances of conceiving.
What is the current status of trial NCT05390606?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2022-06-15. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT05390606?
The interventions under investigation include: Flourish HEC and BioGenesis (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05390606?
This trial is sponsored by Vaginal Biome Science, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05390606's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI